Which medications in the drug class Antibiotics, Other are used in the treatment of Amebiasis?

Updated: Jul 19, 2019
  • Author: Vinod K Dhawan, MD, FACP, FRCPC, FIDSA; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

Antibiotics, Other

Several agents are active against anaerobic bacteria and protozoa. Metronidazole is the drug of choice for symptomatic, invasive disease; paromomycin is the drug of choice for noninvasive disease. Because parasites persist in the intestines of 40-60% of patients treated with metronidazole, this drug should be followed with paromomycin to cure luminal infection. Do not give the 2 medications at the same time; the diarrhea that often results from paromomycin might be confused with continuing active intestinal disease from the parasite.

Metronidazole (Flagyl)

Metronidazole kills trophozoites of Entamoeba histolytica in intestines and tissue but does not eradicate cysts from intestines. It appears to be absorbed into cells. Intermediate metabolized compounds are formed and bind DNA and inhibit protein synthesis, causing cell death. Antimicrobial effect may be due to production of free radicals. Metronidazole is indicated for invasive amebiasis.

Tinidazole (Tinidazole)

Tinidazole is a 5-nitroimidazole derivative used to treat susceptible protozoal infections. The mechanism by which it acts against Giardia and Entamoeba species is not known. Tinidazole is indicated for treatment of intestinal amebiasis and amebic liver abscess caused by E histolytica in adults and children aged 3 years and older.


Paromomycin is an amebicidal and antibacterial aminoglycoside obtained from a strain of Streptomyces rimosus; it is poorly absorbed and is active only against the intraluminal form of amebiasis. Used to eradicate cysts of E histolytica after treatment with metronidazole or tinidazole for invasive disease.

Parasite biochemical pathways are sufficiently different from those of the human host to allow selective interference by chemotherapeutic agents in relatively small doses.

Iodoquinol (Yodoxin)

Iodoquinol is a halogenated hydroxyquinoline that is a luminal amebicide; it acts primarily in the bowel lumen because it is poorly absorbed. It is best tolerated when given with meals. Because iodoquinol is active only against intraluminal form of amebiasis, it is used to eradicate cysts of E histolytica after treatment of invasive disease.

Chloroquine phosphate (Aralen)

Chloroquine phosphate inhibits growth by concentrating within acid vesicles of the parasite, thereby increasing the organism's internal pH. It also inhibits the organism's hemoglobin utilization and metabolism.

In vitro studies involving trophozoites of E histolytica demonstrate that chloroquine possesses amebicidal activity comparable to that of emetine. It is highly effective in treating amebic liver abscess when administered with emetine or dehydroemetine; however, like emetine and dehydroemetine, it is not effective against luminal forms. Irreversible retinal damage does not occur with the dosage and treatment duration used for treatment of hepatic amebiasis.

Dehydroemetine (Mebadin)

Dehydroemetine is preferred to emetine because it is less toxic. It eradicates amebic tissue infections, including liver abscess, but does not act on luminal forms. To eradicate a bowel luminal infection, a luminal amebicide must be used as well. Dehydroemetine is effective only against trophozoites, not against cysts. In the United States, it is available only from the Parasitic Disease Drug Service of the Centers for Disease Control and Prevention (CDC).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!